Quant Mutual Fund advises aggressive portfolio rebalancing amid improving market conditions, citing attractive valuations and strong liquid...

Amazon has signed a $30 million (around ₹280 crore) agreement with the Good Rice Alliance, backed by Bayer, Temasek’s GenZero and Shell, to...

"In the meeting as part of stakeholder consultations, the committee has desired to have the view of Organisation of Pharmaceutical Producer...

The IPA wants the government to accord infrastructure status to the Active Pharmaceutical Ingredients (API) industry, and provide a boost t...

"The shipments of hydroxychloroquine to the US are likely to start next week. Indian pharma companies are committed to meet both, domestic ...

The approved scheme will promote bulk drug parks for financing common infrastructure facilities in three bulk drug parks with a financial i...

The statement further said that the alliance is working closely with the International generic and biosimilar medicines association, the WH...

Indian Pharmaceutical Alliance had noted that the industry annually receives around Rs 3300 to Rs 5500 crore in expired or damaged stock an...

Chemicals and Fertilisers ministry in a statement issued last week had said that the Department of Pharmaceuticals (DoP) is considering a c...

We must first assess the need of the pharma sector and then evaluate whether mere change of ownership would meet its needs.

If a country feels that a provision or policy of another nation discriminates against its companies, it can challenge that under WTO's disp...

Pharma industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to ...

A Group of Ministers is finalising the National Pharmaceutical Pricing Policy (NPPP), which seeks to fix the prices of 348 essential drugs.

DoP is considering linking mkt prices of medicines to rates at which govt procures generic drugs in bulk for its hospitals and health progr...

"The IPA estimates that domestic price reductions alone will result in aggregate loss of sales of nearly Rs 3,000 crore, to the industry," ...

The US drug regulator has inspected the manufacturing plants of at least half-a-dozen Indian drugmakers, raising hopes that these companies...

Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the...